Article
Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of…
ISRN Cardiology · 2013 · Tadashi Wada, author Makoto Nakahama, author Hironobu Toda, author Atsuyuki Watanabe, author Katsushi Hashimoto, author Ritsuko Terasaka, author Kazufumi Nakamura, author Nobuyuki Yamada, author Hiroshi Ito, author A. Becker, Academic Editor H. Nathoe, Academic Editor C. Vassalle, Academic Editor
Key facts
| Title | Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease |
|---|---|
| First author | Tadashi Wada, author Makoto Nakahama, author Hironobu Toda, author Atsuyuki Watanabe, author Katsushi Hashimoto, author Ritsuko Terasaka, author Kazufumi Nakamura, author Nobuyuki Yamada, author Hiroshi Ito, author A. Becker, Academic Editor H. Nathoe, Academic Editor C. Vassalle, Academic Editor |
| Journal | ISRN Cardiology |
| Published | Feb 1, 2013 |
| DOI | 10.1155/2013/518968 |
| Devices mentioned | K082873, K200456, K832607, P060033S057 |
| Product codes mentioned | DQX, GWM |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1